KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veon (VEON) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Veon (VEON) over the last 17 years, with Q2 2025 value amounting to $1.3 billion.

  • Veon's Cash & Equivalents rose 4872.39% to $1.3 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $1.3 billion, marking a year-over-year increase of 4872.39%. This contributed to the annual value of $1.7 billion for FY2024, which is 1119.87% down from last year.
  • Latest data reveals that Veon reported Cash & Equivalents of $1.3 billion as of Q2 2025, which was up 4872.39% from $1.7 billion recorded in Q4 2024.
  • Veon's 5-year Cash & Equivalents high stood at $2.5 billion for Q2 2023, and its period low was $6.0 million during Q4 2022.
  • Over the past 5 years, Veon's median Cash & Equivalents value was $1.7 billion (recorded in 2021), while the average stood at $1.4 billion.
  • As far as peak fluctuations go, Veon's Cash & Equivalents tumbled by 8888.89% in 2022, and later soared by 3160000.0% in 2023.
  • Over the past 5 years, Veon's Cash & Equivalents (Quarter) stood at $54.0 million in 2021, then plummeted by 88.89% to $6.0 million in 2022, then skyrocketed by 31600.0% to $1.9 billion in 2023, then fell by 11.2% to $1.7 billion in 2024, then decreased by 24.1% to $1.3 billion in 2025.
  • Its Cash & Equivalents stands at $1.3 billion for Q2 2025, versus $1.7 billion for Q4 2024 and $862.0 million for Q2 2024.